World May 4, 2021
White House backs Pfizer’s move to begin vaccine exports
by Josh Wingrove
Early U.S. production wasn’t subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.
White House backs Pfizer’s move to begin vaccine exports
Early U.S. production wasn’t subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.
Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds
A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.
Japan to approve Moderna vaccine as soon as May 21, report says
The Moderna vaccine would be the second to get approved in Japan and will be used in the nation’s large inoculation centers that will open in Tokyo and Osaka from May 24, the report said.
Japanese frustrated over vaccine rollout after learning of EU exports
The EU has said that it had authorized some 52.3 million doses made in European factories for export to Japan, the highest volume among all 43 countries to which vaccines have been shipped.
Tokyo to get SDF-staffed, large-scale vaccination site amid slow rollout
Medically licensed SDF personnel are expected to administer Moderna and AstraZeneca vaccines to about 900,000 people age 65 or older living in the capital and neighboring prefectures.
Deal for more Pfizer shots may allow Japan to cut reliance on AstraZeneca vaccine
Pfizer is expected to provide an additional 50 million doses by September in a contract that could be agreed on this month, a report said Wednesday.
Japan to secure enough vaccines for all residents by end of September
Pfizer has accepted Prime Minister Yoshihide Suga's request to supply additional doses of the shots, vaccine chief Taro Kono said Sunday.
Some Japanese government sources said Suga is arranging to hold talks with Pfizer CEO Albert Bourla via telephone on Friday or Saturday Japan time.
South African variant can 'break through' Pfizer vaccine, Israeli study says
The study suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain.
Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds
The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.
Japan reports 47 anaphylaxis cases after 580,000 vaccine shots, but ministry confirms safety
All recovered after receiving treatment, according to the ministry, with its panel of experts concluding that there are no serious concerns about the safety of the vaccine at this time.
The ex-Pfizer scientist who became an anti-vaccination hero
In recent months, Michael Yeadon has emerged as an unlikely hero of the so-called anti-vaxxers, whose adherents question the safety of many vaccines, including for the coronavirus.